Performance Health Files for IPO

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Performance Health Files for IPO

© Thinkstock

Performance Health Holdings has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were listed in the report, but the offering is valued up to $100 million, although this number is usually just a placeholder. The company intends to list on the Nasdaq Global Market under the symbol PHC.

The underwriters for the offering are Credit Suisse, Jefferies, Baird, UBS Investment Bank, William Blair and SunTrust Robinson Humphrey.

This is a fast-growing, highly profitable, global consumer branded health, wellness and self-care company. Its products, distributed through clinical and retail channels both in the United States and internationally, help consumers accelerate recovery, relieve pain, increase strength, improve performance and enhance their quality of life. Performance Health believes that hands-on health care practitioners trust and embrace its brands, as demonstrated by high in-clinic usage and recommendations to their patients and clients, who in turn can purchase products directly from their practitioner or at retail.
[nativounit]
This practitioner recommendation enhances the brands’ visibility, credibility and loyalty among consumers and is an important competitive advantage that also drives retail demand. The company believes the demand for its market leading brands, as well as the growth of its business, will continue to be supported by secular shifts in consumers’ increasingly active lifestyles, an aging population and lower-cost self-care.

The company intends to use the proceeds from this offering to prepay some or all of the outstanding principal on the term loan under its second lien credit facility. The remainder of the proceeds will be used for working capital and general corporate purposes.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618